Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Chimerix Inc CMRX

Healthcare Biotechnology
Chimerix, Inc. is a biotechnology company. The Company is focused on developing medicines that address unmet medical needs. The Company's product Imipridones is a cancer therapy that provides ONC201, which is in clinical-stage development for H3 K27M-mutant glioma as its lead indication. In addition, imipridone ONC206 is in dose-escalating clinical trials. Imipridones target specific G protein... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CMRX)

Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting

GlobeNewswire November 11, 2024

Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire November 7, 2024

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024

GlobeNewswire November 1, 2024

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 18, 2024

Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 3, 2024

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 30, 2024

Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire August 13, 2024

Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024

GlobeNewswire August 6, 2024

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 5, 2024
View More News ››

Opinion & Analysis (NDAQ:CMRX)

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Streetwise Reports April 29, 2020
View More Opinion ››

Bullboard Posts (NDAQ:CMRX)

monkeypox play

.
thedave2006 - August 5, 2022

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

<< View Post To Watch Video >>
HarryPerkins - November 18, 2021

🎉📣FSD Pharma's Research and Clinical Advisory Board📢

Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical...
HarryPerkins - November 17, 2021

📣FSD Pharma:Agreement Signed With Covar Pharmaceuticals📢📣

<< View Post To Watch Video >>
HarryPerkins - November 10, 2021

📢📣FSD Pharma forms agreement with Covar Pharmaceuticals 📢

<< View Post To Watch Video >>
HarryPerkins - October 30, 2021

How much this stock worth?

Today the price is under $5
Milton2014 - February 22, 2016
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »